Avinger Reports Third Quarter 2024 Results Nov 7, 2024 04:05PM
Avinger to Announce Third Quarter 2024 Results on November 7, 2024 Oct 29, 2024 08:00AM
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention Oct 24, 2024 08:00AM
Avinger (AVGR) Issues New U.S. Patent, Receives Notices of Allowance for Five Additional U.S. Patents Sep 18, 2024 08:03AM
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents Sep 18, 2024 08:00AM


Aug 20, 2024 08:30AM Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
Aug 8, 2024 04:01PM Avinger Reports Second Quarter 2024 Results
Aug 5, 2024 08:12AM Avinger (AVGR) Appoints Thomas P. Davis as Chief Medical Officer
Aug 5, 2024 08:00AM Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
Jul 29, 2024 08:45AM Avinger to Announce Second Quarter 2024 Results on August 8, 2024
Jun 17, 2024 04:05PM Avinger Announces Closing of up to $24 Million Public Offering
Jun 17, 2024 04:05PM Avinger Announces Closing of up to $24 Million Public Offering
Jun 14, 2024 08:03AM Avinger (AVGR) Prices Up to $24M Share and Warrant Offering at $1.66/sh
Jun 14, 2024 08:00AM Avinger Announces Pricing of up to $24 Million Public Offering
Jun 14, 2024 08:00AM Avinger Announces Pricing of up to $24 Million Public Offering